0
Gene Therapy for Psychiatric Disorders
Robert M. Sapolsky, Ph.D.
Chronic Fatigue Syndrome: A Review
Niloofar Afari, Ph.D.; Dedra Buchwald, M.D.
Childhood Obsessive-Compulsive Personality Traits in Adult Women With Eating Disorders: Defining a Broader Eating Disorder Phenotype
Marija Brecelj Anderluh, M.D.; Kate Tchanturia, Ph.D.; Sophia Rabe-Hesketh, Ph.D.; Janet Treasure, Ph.D., F.R.C.P., F.R.C.Psych.
Topiramate in the Treatment of Binge Eating Disorder Associated With Obesity: A Randomized, Placebo-Controlled Trial
Susan L. McElroy, M.D.; Lesley M. Arnold, M.D.; Nathan A. Shapira, M.D., Ph.D.; Paul E. Keck, Jr., M.D.; Norman R. Rosenthal, M.D.; M. Rezaul Karim, Ph.D.; Marc Kamin, M.D.; James I. Hudson, M.D., Sc.D.
The Longitudinal Course of Borderline Psychopathology: 6-Year Prospective Follow-Up of the Phenomenology of Borderline Personality Disorder
Mary C. Zanarini, Ed.D.; Frances R. Frankenburg, M.D.; John Hennen, Ph.D.; Kenneth R. Silk, M.D.
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Martina C.M. Ryan, M.B., M.R.C.Psych.; Patrick Collins, M.Sc., Ph.D.; Jogin H. Thakore, M.B., Ph.D., M.R.C.Psych., M.R.C.P.I.
Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics
Jean-Pierre Lindenmayer, M.D.; Pal Czobor, Ph.D.; Jan Volavka, M.D., Ph.D.; Leslie Citrome, M.D., M.P.H.; Brian Sheitman, M.D.; Joseph P. McEvoy, M.D.; Thomas B. Cooper, M.A.; Miranda Chakos, M.D.; Jeffrey A. Lieberman, M.D.
Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study
Michael Poyurovsky, M.D.; Ilanit Isaacs, M.D.; Camil Fuchs, Ph.D.; Michael Schneidman, M.D.; Sarit Faragian, M.A.; Ronit Weizman, M.D.; Abraham Weizman, M.D.
Subjective Experience and D2 Receptor Occupancy in Patients With Recent-Onset Schizophrenia Treated With Low-Dose Olanzapine or Haloperidol: A Randomized, Double-Blind Study
Lieuwe de Haan, M.D., Ph.D.; Marion van Bruggen, M.D.; Jules Lavalaye, M.D., Ph.D.; Jan Booij, M.D., Ph.D.; Peter M.A.J. Dingemans, Ph.D.; Don Linszen, M.D., Ph.D.
PET Studies of the Influences of Nicotine on Neural Systems in Cigarette Smokers
Jed E. Rose, Ph.D.; Frederique M. Behm, B.S.; Eric C. Westman, M.D.; Roy J. Mathew, M.B.; Edythe D. London, Ph.D.; Thomas C. Hawk, B.S.; Timothy G. Turkington, Ph.D.; R. Edward Coleman, M.D.
Inhibitory Effect of Hippocampal 5-HT1A Receptors on Human Explicit Memory
Fumihiko Yasuno, M.D., Ph.D.; Tetsuya Suhara, M.D., Ph.D.; Takashi Nakayama, M.D.; Tetsuya Ichimiya, M.D., Ph.D.; Yoshiro Okubo, M.D., Ph.D.; Akihiro Takano, M.D., Ph.D.; Tomomichi Ando, M.D.; Makoto Inoue, M.D., Ph.D.; Jun Maeda, M.S.; Kazutoshi Suzuki, Ph.D.
Delusional Thoughts and Regional Frontal/Temporal Cortex Metabolism in Alzheimer’s Disease
David L. Sultzer, M.D.; Charles V. Brown, M.D.; Mark A. Mandelkern, M.D., Ph.D.; Michael E. Mahler, M.D.; Mario F. Mendez, M.D., Ph.D.; Stephen T. Chen, M.D.; Jeffrey L. Cummings, M.D.
Fatigue in Obstructive Sleep Apnea: Driven by Depressive Symptoms Instead of Apnea Severity?
Wayne A. Bardwell, Ph.D.; Polly Moore, Ph.D.; Sonia Ancoli-Israel, Ph.D.; Joel E. Dimsdale, M.D.
The Declaration of Helsinki and Clinical Trials: A Focus on Placebo-Controlled Trials in Schizophrenia
William T. Carpenter, Jr., M.D.; Paul S. Appelbaum, M.D.; Robert J. Levine, M.D.
Are Top Journals Biased Against Eating Disorders Topics?
Susie Frost, M.Sc.; Rebecca Murphy, B.A.; Peter Webster, M.A., M.R.C.Psych.; Ulrike Schmidt, Ph.D., M.R.C.Psych.
The Relation Between Eating Disorders and Components of Perfectionism
Cynthia M. Bulik, Ph.D.; Federica Tozzi, M.D.; Charles Anderson, M.A.; Suzanne E. Mazzeo, Ph.D.; Steve Aggen, Ph.D.; Patrick F. Sullivan, M.D., F.R.A.N.Z.C.P.
Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study
Murray A. Raskind, M.D.; Elaine R. Peskind, M.D.; Evan D. Kanter, M.D.; Eric C. Petrie, M.D.; Allen Radant, M.D.; Charles E. Thompson, M.D.; Dorcas J. Dobie, M.D.; David Hoff, PA-C; Rebekah J. Rein, J.D.; Kristy Straits-Tröster, Ph.D.; Ronald G. Thomas, Ph.D.; Miles M. McFall, Ph.D.
Changes in Regional Cerebral Blood Flow With Venlafaxine in the Treatment of Major Depression
Julia Davies, M.Phil.; Keith R. Lloyd, M.D.; Ivor K. Jones, B.Sc.; Anna Barnes, Ph.D.; Lyn S. Pilowsky, Ph.D.
Differentiation of Geriatric Major Depression From Alzheimer’s Disease With CSF Tau Protein Phosphorylated at Threonine 231
Katharina Buerger, M.D.; Raymond Zinkowski, Ph.D.; Stefan J. Teipel, M.D.; Hiroyuki Arai, M.D., Ph.D.; John DeBernardis, Ph.D.; Daniel Kerkman, Ph.D.; Cheryl McCulloch, B.S.; Frank Padberg, M.D.; Frank Faltraco, M.D.; Alexander Goernitz, M.D.; Tero Tapiola, M.D.; Stanley I. Rapoport, Ph.D.; Tuula Pirttilä, M.D., Ph.D.; Hans-Jürgen Möller, M.D.; Harald Hampel, M.D.
Parahippocampal Volume Deficits in Subjects With Aging-Associated Cognitive Decline
Johannes Pantel, M.D., Ph.D.; Benita Kratz, M.Sc.; Marco Essig, M.D.; Johannes Schröder, M.D., Ph.D.
Older Patients With Schizophrenia: Nature of Dwelling Status and Symptom Severity
Sanjay Gupta, M.D.; Charles Steinmeyer, Ph.D.; Bradford Frank, M.D., M.P.H.; Kari Lockwood, R.N.; Barbara Lentz, R.N.; Kay Schultz, R.N.
Electrolyte-Balanced Sports Drink for Polydipsia-Hyponatremia in Schizophrenia
FREDERIC M. QUITKIN, M.D.; AMIR GARAKANI, M.D.; KATIE E. KELLY, B.A.
Omega-3 Fatty Acids for Depression in Pregnancy
CHIH-CHIANG CHIU, M.D.; SHIH-YI HUANG, Ph.D.; WINSTON W. SHEN, M.D.; KUAN-PIN SU, M.D.
Biperiden for Excessive Sweating From Methadone
CARLO CAFLISCH, M.D.; BERND FIGNER, M.A.; DOMINIQUE EICH, M.D.
Dr. Shear Replies
M. KATHERINE SHEAR, M.D.
Real-Life Research
ELLEN L. LIPMAN, M.D., F.R.C.P.; MICHAEL H. BOYLE, M.S.W., Ph.D.
Diabetes and Atypical Neuroleptics
FRANK D. GIANFRANCESCO, Ph.D.
Diabetes and Atypical Neuroleptics
WAYNE K. GELLER, M.D.; WAYNE MacFADDEN, M.D.
Hagiographic Treatment of C.G. Jung
ROBERT M. KAPLAN, M.B.Ch.B., F.R.A.N.Z.C.P., M.A.
Brain Changes and Placebo
RENÉ J. MULLER, Ph.D.
Dr. Sernyak and Colleagues Reply
MICHAEL J. SERNYAK, M.D.; DOUGLAS L. LESLIE, Ph.D.; RENATO ALARCON, M.D.; MIKLOS LOSONCZY, M.D., Ph.D.; ROBERT ROSENHECK, M.D.
Dr. Mayberg and Colleagues Reply
HELEN S. MAYBERG, M.D.; J. ARTURO SILVA, M.D.; STEVEN K. BRANNAN, M.D.; JANET L. TEKELL, M.D.; RODERICK K. MAHURIN, Ph.D.; SCOTT McGINNIS, M.D.; PAUL A. JERABEK, Ph.D.
Dr. Hayward and Colleagues Reply
CHRIS HAYWARD, M.D., Ph.D.; BENJAMIN H. FLORES, M.D.; H. BRENT SOLVASON, M.D.; PENELOPE ZEIFERT, Ph.D.; BRENT T. HARRIS, M.D., Ph.D.
Misdiagnosis of Conversion Disorder
JON STONE, M.R.C.P.; MARTIN ZEIDLER, M.D.; MICHAEL SHARPE, M.D.
Dr. Sato and Colleagues Reply
TETSUYA SATO, M.D., Ph.D.; RONALD BOTTLENDER, M.D.; NIKOLAUS KLEINDIENST, M.S.; ANDREAS SCHRÖTER, M.S.; HANS-JÜRGEN MÖLLER, M.D.
Symptom Factors and Clinical Subtypes in Mania
FREDERICK CASSIDY, M.D.; BERNARD J. CARROLL, M.B., B.S., Ph.D.
Affective Instability in Personality Disorders
PAUL S. LINKS, M.D., F.R.C.P.(C.); MARNIN J. HEISEL, Ph.D.; ALLAN GARLAND, B.Sc.
Dr. Schiffman and Colleagues Reply
JASON SCHIFFMAN, M.A.; MORTEN EKSTROM, M.D.; JOSEPH LaBRIE, M.A.; FINI SCHULSINGER, M.D.; HOLGER SORENSEN, M.D.; SARNOFF MEDNICK, Ph.D., Dr.Med.
Dr. Koenigsberg and Colleagues Reply
HAROLD W. KOENIGSBERG, M.D.; PHILIP D. HARVEY, Ph.D.; VIVIAN MITROPOULOU, M.A.; ANTONIA NEW, M.D.; MARIANNE GOODMAN, M.D.; LARRY J. SIEVER, M.D.
Promoting Mental Health Internationally
CLÁUDIO E.M. BANZATO, M.D., Ph.D.; JUAN E. MEZZICH, M.D., Ph.D.
Depression, IV: STAR*D Treatment Trial for Depression
A. John Rush, M.D.; Madhukar Trivedi, M.D.; Maurizio Fava, M.D.
The Luck Factor
Richard G. Druss, M.D.